Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

EDP 420

Next Previous
X
Search
Drug Profile

EDP 420

Alternative Names: EDP-420; EP-013420; EP-13420; S-013420

Latest Information Update: 05 Nov 2023

Price : $50 *
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Enanta Pharmaceuticals
  • Developer Enanta Pharmaceuticals; Shionogi
  • Class Antibacterials; Macrolides; Organic bridged compounds
  • Mechanism of Action Protein 50S ribosomal subunit inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity Yes

Highest Development Phases

  • Discontinued Community-acquired pneumonia; Helicobacter infections; Mycobacterium avium complex infections; Respiratory tract infections; Skin and soft tissue infections; Tuberculosis

Most Recent Events

  • 25 May 2010 Discontinued - Phase-II for Respiratory tract infections in Japan (PO)
  • 28 Oct 2008 Preclinical trials in Skin and soft tissue infections in USA (PO)
  • 28 Oct 2008 Preclinical pharmacodynamics data presented at the 48th Annual Interscience Conference on Antimicrobial Agents and Chemotherapy and 46th Annual Meeting of the Infectious Diseases Society of America (ICAAC/IDSA-2008) ,,

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top